Project Grant RF1AG079185
Award Date
9/15/22
Completion Date
8/31/25
Dollars Obligated
$4.5M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
The University of California, Irvine was awarded a $773,816 Project Grant from the National Institute on Aging (CFDA 93.866 - Aging Research) to conduct cell-type-specific and spatial proteogenomics analysis of aberrant RNA splicing and misfolded proteins in Alzheimer's-related tauopathies. The research aims to generate single-cell spatial proteo-transcriptomics maps to molecularly characterize aberrant RNA splicing and abnormal protein products in specific brain cell types in mouse models and...
This $3,845,311 federal Project Grant award was provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to the University of California, San Diego (UCSD) from August 2024 through April 2029. The grant aims to generate age-equivalent neurons from mild cognitive impairment (MCI) patients to investigate early determinants of Alzheimer's disease (AD). Key goals include: Integrating polygenic risk scores for AD with multi-omic analysis of MCI patient-derived...
The University of California, San Diego will receive $3,868,694 under a three-year Project Grant from the National Institute on Aging, part of the National Institutes of Health, to develop selective amyloid-responsive fluorescent probes. The goal is to uncover design principles for probes that can selectively detect aggregated forms of alpha-synuclein or tau versus amyloid-beta in solution and tissue. The university will also develop a method to characterize the distribution of amyloidogenic...
The National Institutes of Health's National Institute on Aging awarded a $4.7 million Project Grant to the University of California, Davis under the Aging Research program (CFDA 93.866) to investigate neuropathogenesis in the interoceptive-allostatic network as part of an animal model of early Alzheimer's disease pathogenesis. The grant will fund detailed neuroimaging and histological analyses of the brain network responsible for generating and regulating affect in rhesus monkeys administered...
This $4.49 million project grant from the National Institutes of Health's National Institute on Aging will fund research at The Washington University to investigate the relationship between amyloid plaque deposition, cellular metabolic dysfunction, and functional brain organization in Alzheimer's disease (AD) mice models. Over three years, the researchers will use multi-photon fluorescence lifetime imaging microscopy, multi-parametric photoacoustic microscopy, and wide-field optical imaging to...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $2,251,070 to the University of California Irvine through July 2025. The grant supports research to develop new statistical methodologies for analyzing Alzheimer's disease data from longitudinal cohort studies. Key deliverables include methods for assessing prediction precision for recurrent event survival data using time-dependent ROC and C-index...
The National Institute on Aging (NIA), under its Aging Research program (CFDA 93.866), has awarded a $2,112,826 cooperative agreement to the University of California, San Diego (UCSD) to advance a CRISPR-based therapeutic for Alzheimer's disease (AD) towards pre-IND stage. The project aims to determine the optimal gene-editing combination to edit the APP gene, which plays a central role in AD pathogenesis, and shift the APP cleavage pathway from pathologic to physiologic. UCSD will evaluate...
The National Institutes of Health's National Institute on Aging awarded a $7,432,562 project grant to the Regents of the University of California, San Francisco on September 15, 2022 under the Aging Research program (CFDA 93.866). The grant will support research to elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes through 2025. Specifically, the University of California, San Francisco will use CRISPR and single-cell RNA sequencing...
This $15,046,454 project grant from the National Institutes of Health National Institute on Aging, under the Aging Research program (CFDA 93.866), will fund research at the University of California, San Diego to improve understanding of proteomic changes preceding Alzheimer's disease and related dementias. The research will analyze longitudinal plasma samples from 2,836 women in the Women's Health Initiative Memory Study cohort using the Somamscan proteomics platform to identify novel...
This Project Grant award, valued at $10,847,672 and funded by the National Institute on Aging's Aging Research program (CFDA 93.866), supports research on the mechanisms underlying cerebral amyloid angiopathy (CAA) and its relationship to Alzheimer's disease pathology. The primary awardee, J. David Gladstone Institutes, will conduct comprehensive studies using human postmortem brain samples, single-cell genomics, and mouse models to elucidate how microglia regulate the balance between vascular...